Literature DB >> 2982845

Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.

H G Bull, N A Thornberry, M H Cordes, A A Patchett, E H Cordes.   

Abstract

Two novel peptide analogs, N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and the corresponding L-lysyl-L-proline derivative, have been demonstrated to be potent competitive inhibitors of purified rabbit lung angiotensin-converting enzyme: Ki = 2 and 1 X 10(-10) M, respectively, at pH 7.5, 25 degrees C, and 0.3 M chloride ion. Second-order rate constants for addition of these inhibitors to enzyme under the same conditions are in the range 1-2 X 10(6) M-1 s-1; first-order rate constants for dissociation of the EI complexes are in the range 1-4 X 10(-4) s-1. The association rate constants are similar to those measured for D-3-mercapto-2-methylpropanoyl-L-proline, captopril, but the dissociation rate constants are severalfold slower and account for the higher affinity of these inhibitors for the enzyme. The dissociation constant for the EI complex containing N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline is pH-dependent, and reaches a minimum at approximately pH 6: Ki = 4 +/- 1 X 10(-11) M. The pH dependence is consistent either with a model for which the protonation state of the secondary nitrogen atom in the inhibitor determines binding affinity, or one for which ionizations on the enzyme alone influence affinity for these inhibitors. The affinity of this inhibitor for the zinc-free apoenzyme is 2 X 10(4) times less than for the zinc-free apoenzyme is 2 X 10(4) times less than that for the holoenzyme. If considered as a "collected product" inhibitor, N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline appears to derive an additional factor of 375 M in its affinity for the enzyme compared to that of the two products of its hypothetical hydrolysis, a consequence of favorable entropy effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982845

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Metallopeptide-promoted inactivation of angiotensin-converting enzyme and endothelin-converting enzyme 1: Toward dual-action therapeutics.

Authors:  Nikhil H Gokhale; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2006-07-28       Impact factor: 3.358

2.  Encoded combinatorial chemistry: synthesis and screening of a library of highly functionalized pyrrolidines.

Authors:  D Maclean; J R Schullek; M M Murphy; Z J Ni; E M Gordon; M A Gallop
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Effect of temperature and chloride on steady-state inhibition of angiotensin I-converting enzyme by enalaprilat and ramiprilat.

Authors:  A Skoglof; P O Göthe; J Deinum
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

4.  Pharmacological properties of FPL 63547, a novel inhibitor of angiotensin-converting enzyme.

Authors:  R D Carr; L Higgs; P G Killingback; A K Nicol; S E O'Connor; A Robson; E Wells; W T Simpson
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

Review 5.  Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  S G Lancaster; P A Todd
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 6.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

7.  Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.

Authors:  Jason C Kwan; Erika A Eksioglu; Chen Liu; Valerie J Paul; Hendrik Luesch
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

8.  Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.

Authors:  Gillian I Rice; Daniel A Thomas; Peter J Grant; Anthony J Turner; Nigel M Hooper
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

9.  Purified angiotensin converting enzyme from Rana esculenta ovary influences ovarian steroidogenesis in vitro.

Authors:  A Miano; L Quassinti; E Maccari; O Murri; D Amici; M Bramucci
Journal:  J Physiol Biochem       Date:  2003-12       Impact factor: 4.158

10.  Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.

Authors:  David G Levitt; Rik C Schoemaker
Journal:  BMC Clin Pharmacol       Date:  2006-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.